Beginning in 2025, the American Quarter Horse Association lowered the maximum permitted plasma concentration of dexamethasone from the 2024 threshold of 3.0 nanograms per milliliter to 0.5 nanograms ...

Eclipse Life Sciences, Inc., a privately held clinical-stage biopharmaceutical company focused on the development of novel therapies for ophthalmic diseases, today announced that it has completed ...

AZD0120, a rapidly manufactured CAR T product, was used successfully in a small number of patients with multiple myeloma with ...